Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

is part of an international team (including other groups at the Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Institute of Clinical Trials and Methodology (ICTM) awarded funds for $2.3 from the Gates Foundation. Up to 30,000 healthcare workers from across the globe will be recruited to participate in the clinical trial co-led by Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø, which aims to establish whether chloroquine, a widely prescribed anti-malaria drug, could also prevent people from getting COVID-19.